Funded Tech Companies
Illexcor Therapeutics
Illexcor Therapeutics is a biopharmaceutical venture, located in Richmond. Financial backing came from Zynext Ventures.
Company Overview
Company Name
Illexcor Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
Richmond, VA Undisclosed
USA
Richmond, VA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Our mission is to discover, develop and deliver next generation therapies that improve the lives and outcomes of people living with hematologic diseases. We are focused on advancing next generation oral therapies for the treatment of sickle cell disease. Our goal is to develop best-in-class oral Hemoglobin S polymerization inhibitors that can provide profound disease-modifying clinical benefits. Our lead drug ILX002 is the first of its kind that binds to Hemoglobin S and directly blocks polymerization and sickling.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/13/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Fleischman
Company Investors
Browse more funded tech companies:
Ilkos Therapeutics | Illuma Labs
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs